← Open Payments lookup

SYED RIZVI: Open Payments

NPI 1396824363 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,309 in 69 payments from 15 companies in 2025. Trend: 2023 $1,413 · 2024 $1,788 · 2025 $1,309

Food & beverage: $1,309
CompanyPaymentsAmount
Alkermes, Inc.10$187
ABBVIE INC.13$185
Otsuka America Pharmaceutical, Inc.8$145
Vanda Pharmaceuticals Inc.5$131
Axsome Therapeutics, Inc.5$113
Lundbeck LLC5$102
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$95
Neurocrine BioSciences, Inc.4$74
E.R. Squibb & Sons, L.L.C.3$69
Corium, LLC4$64

Products named: ARISTADA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, Auvelity, FANAPT, CAPLYTA, INGREZZA.

Industry payments across VA — which companies pay providers there.